Comparative evaluation under routine conditions of the nitrate reduction assay, the proportion assay and the MGIT 960 assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis  Leila de Souza Fonseca; Gisele Betzler de Oliveira Vieira; Luciana Fonseca Sobral; Elizabete Oliveira Ribeiro; Anna Grazia Marsico PAGE: 142-144 | DOI: 10.1590/S0074-02762012000100021

Drug Susceptibility of Brazilian Strains of Mycobacterium bovis Using Traditional and Molecular Techniques Patrícia M Parreiras, Francisco CF Lobato, Andréa P Alencar, Telma de Figueiredo, Harrison M Gomes, Neio Boéchat, Andrey P Lage, Ronnie A Assis, Márcia AS Pereira, Patrícia R Souza, Pedro MPC Mota, Philip N Suffys PAGE: 749-752

Variation in Susceptibility to Benznidazole in Isolates Derived from Trypanosoma cruzi Parental Strains VM Veloso, CM Carneiro, MJO Toledo, M Lana, E Chiari, WL Tafuri,MT Bahia PAGE: 1005-1011

Flow Cytometry as a Tool to Identify Mycobacterium tuberculosis Interaction with the Immune System and Drug Susceptibility Maria da Gloria Bonecini-Almeida PAGE: 491-494

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease Margoth Moreno; Daniella A D'ávila; Marcelo N Silva; Lúcia MC Galvão; Andrea M Macedo; Egler Chiari; Eliane D Gontijo; Bianca Zingales PAGE: 918-924 | DOI: 10.1590/S0074-02762010000700014

In Vitro Responses of Plasmodium falciparum Isolates to Five Antimalaria Drugs in French Guiana during 1994 and 1995 Jean-Marc Reynes , Josiane Fargette, Pascal Gaborit,Steve Yarde PAGE: 251-252